Medicine and Dentistry
Parkinson's Disease
100%
Insulin Resistance
100%
Polo Like Kinase 2
100%
Synuclein
100%
Diabetes
44%
Reactive Oxygen Species
33%
Dopaminergic Neuron
33%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
22%
SH-SY5Y
22%
Lipid Diet
11%
In Vitro
11%
Diabetes Mellitus
11%
Disease
11%
Ex Vivo
11%
down Regulation
11%
Cell Function
11%
Impaired Glucose Tolerance
11%
Hyperactivity
11%
Pulse Rate
11%
Maturity Onset Diabetes of the Young
11%
Peroxisome Proliferator Activated Receptor
11%
Insulin Treatment
11%
Hyperactivation
11%
Proteinase K
11%
Neuroscience
Parkinson's Disease
100%
Synuclein
100%
Polo Like Kinase 2
100%
In Vivo
50%
Reactive Oxygen Species
50%
Dopaminergic Neuron
50%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
33%
In Vitro
16%
Cell Function
16%
Peroxisome Proliferator-Activated Receptor
16%
Hyperactivity
16%
Mitochondrial Function
16%
Proteinase K
16%
Diabetes Mellitus
16%
Pharmacology, Toxicology and Pharmaceutical Science
Polo Like Kinase 2
100%
Parkinson's Disease
100%
Insulin Resistance
100%
Synuclein
100%
Reactive Oxygen Metabolite
33%
Mouse
33%
Dopamine Receptor Stimulating Agent
33%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
22%
Non Insulin Dependent Diabetes Mellitus
11%
Peroxisome Proliferator Activated Receptor
11%
Hyperactivity
11%
Proteinase K
11%
Disease
11%
Diabetes Mellitus
11%
Impaired Glucose Tolerance
11%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
100%
Synuclein
100%
Polo-Like Kinase
100%
Mouse
33%
Dopaminergic
33%
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1alpha
22%
Cell Function
11%
down Regulation
11%
Wild Type
11%
Pulse Rate
11%
Peroxisome Proliferator-Activated Receptor
11%
Impaired Glucose Tolerance
11%
Proteinase K
11%